Skip to search formSkip to main contentSkip to account menu

childhood acute lymphoblastic leukemia in remission

Known as: Pediatric Acute Lymphogenous Leukemia in Remission, Childhood Acute Lymphoid Leukemia in Remission, Childhood ALL in Remission 
Acute lymphoblastic leukemia in children which is not growing and responds to treatment.
National Institutes of Health

Related topics

Related topics

2 relations
Hematopoietic and Lymphoid CellHematopoietic and Lymphoid Tissue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan
Sorafenib, a molecular-targeted agent that inhibits tumor cell proliferation and angiogenesis by inhibiting RAF serine-threonine… 
Highly Cited
2007
Highly Cited
2007
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
Elderly patients with acute myeloid leukemia (AML) have a poor prognosis, which is explained by the disease itself and by host… 
Highly Cited
2005
Highly Cited
2005
Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse
We monitored BCR–ABL transcript levels by quantitative real-time PCR in 103 patients treated with imatinib for chronic myeloid… 
Highly Cited
2005
Highly Cited
2005
Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized…
The question as to whether autologous stem cell transplantation (SCT) after consolidation chemotherapy improves the probability… 
Highly Cited
2005
Highly Cited
2005
Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients.
Highly Cited
2000
Highly Cited
2000
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma.
In the present study, we used a polymerase chain reaction-based (PCR-based) strategy to retrospectively analyze the presence of… 
Highly Cited
1997
Highly Cited
1997
Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
Differentiation therapy with all-trans retinoic acid (ATRA) has marked a major advance and become the first choice drug in the… 
Review
1997
Review
1997
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey
Between January 1991 and January 1994, 40 patients with hairy-cell leukemia (HCL), 30 males and 10 females, with a median age of… 
Highly Cited
1989
Highly Cited
1989
Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabine.
High-dose cytarabine (HDARA-C) is an effective but toxic treatment for acute myeloid leukemia (AML). In order to reduce the… 
Review
1987
Review
1987
Chemotherapy of urothelial tract tumors
Recent data from Phase II trials in patients with advanced transitional cell carcinoma of the urothelial tract suggest… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)